||Recombinant Human CD97 (Accession # NP_001775) was produced in Mouse myeloma cell line, NS0-derived.
|Predicted N Terminal:
||No results obtained: Gln21 predicted
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. Hamann, J. et al. (1996) J. Exp. Med. 184:1185.The ED50 for this effect is typically 0.1-0.6 µg/mL.
||Recombinant Human CD97 has a calculated MW of 42 kDa. In SDS-PAGE migrates as 66-86 kDa, reducing conditions.
||>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).